Abiraterone for treating newly diagnosed metastatic hormone-naïve prostate cancer.

Ewen Cummins, Lorna Sharman Aucott, Clare Robertson, Cynthia Fraser, Rhona Johnston, Thomas Lam, Miriam Giovanna Brazzelli

Research output: Book/ReportCommissioned Report

Original languageEnglish
PublisherEvidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence
Commissioning bodyNational Institute for Health and Care Excellence
Publication statusPublished - 2018

Cite this

Cummins, E., Aucott, L. S., Robertson, C., Fraser, C., Johnston, R., Lam, T., & Brazzelli, M. G. (2018). Abiraterone for treating newly diagnosed metastatic hormone-naïve prostate cancer. Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence.

Abiraterone for treating newly diagnosed metastatic hormone-naïve prostate cancer. / Cummins, Ewen ; Aucott, Lorna Sharman; Robertson, Clare; Fraser, Cynthia; Johnston, Rhona; Lam, Thomas; Brazzelli, Miriam Giovanna.

Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence, 2018.

Research output: Book/ReportCommissioned Report

Cummins, E, Aucott, LS, Robertson, C, Fraser, C, Johnston, R, Lam, T & Brazzelli, MG 2018, Abiraterone for treating newly diagnosed metastatic hormone-naïve prostate cancer. Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence.
Cummins E, Aucott LS, Robertson C, Fraser C, Johnston R, Lam T et al. Abiraterone for treating newly diagnosed metastatic hormone-naïve prostate cancer. Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence, 2018.
Cummins, Ewen ; Aucott, Lorna Sharman ; Robertson, Clare ; Fraser, Cynthia ; Johnston, Rhona ; Lam, Thomas ; Brazzelli, Miriam Giovanna. / Abiraterone for treating newly diagnosed metastatic hormone-naïve prostate cancer. Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence, 2018.
@book{3ede002c1c584958b6d6e8e2037f403a,
title = "Abiraterone for treating newly diagnosed metastatic hormone-na{\"i}ve prostate cancer.",
author = "Ewen Cummins and Aucott, {Lorna Sharman} and Clare Robertson and Cynthia Fraser and Rhona Johnston and Thomas Lam and Brazzelli, {Miriam Giovanna}",
year = "2018",
language = "English",
publisher = "Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence",

}

TY - BOOK

T1 - Abiraterone for treating newly diagnosed metastatic hormone-naïve prostate cancer.

AU - Cummins, Ewen

AU - Aucott, Lorna Sharman

AU - Robertson, Clare

AU - Fraser, Cynthia

AU - Johnston, Rhona

AU - Lam, Thomas

AU - Brazzelli, Miriam Giovanna

PY - 2018

Y1 - 2018

M3 - Commissioned Report

BT - Abiraterone for treating newly diagnosed metastatic hormone-naïve prostate cancer.

PB - Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence

ER -